AAAAAA
Results: 1-25/73
Authors:
Davidsson, P
Paulson, L
Hesse, C
Blennow, K
Nilsson, CL
Citation: P. Davidsson et al., Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two-dimensional electophoresis approach prior to mass spectrometry, PROTEOMICS, 1(3), 2001, pp. 444-452
Authors:
Regland, B
Lehmann, W
Abedini, I
Blennow, K
Jonsson, M
Karlsson, I
Sjogren, M
Wallin, A
Xilinas, M
Gottfries, CG
Citation: B. Regland et al., Treatment of Alzheimer's disease with clioquinol, DEMENT G C, 12(6), 2001, pp. 408-414
Authors:
Tarkowski, E
Liljeroth, AM
Nilsson, A
Minthon, L
Blennow, K
Citation: E. Tarkowski et al., Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease, DEMENT G C, 12(5), 2001, pp. 314-317
Authors:
Davidsson, P
Bogdanovic, N
Lannfelt, L
Blennow, K
Citation: P. Davidsson et al., Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease, DEMENT G C, 12(4), 2001, pp. 243-250
Authors:
Sjogren, M
Davidsson, P
Gottfries, J
Vanderstichele, H
Edman, A
Vanmechelen, E
Wallin, A
Blennow, K
Citation: M. Sjogren et al., The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process, DEMENT G C, 12(4), 2001, pp. 257-264
Authors:
Prince, JA
Feuk, L
Howell, WM
Jobs, M
Emahazion, T
Blennow, K
Brookes, AJ
Citation: Ja. Prince et al., Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): Design criteria and assay validation, GENOME RES, 11(1), 2001, pp. 152-162
Authors:
Prince, JA
Feuk, L
Sawyer, SL
Gottfries, J
Ricksten, A
Nagga, K
Bogdanovic, N
Blennow, K
Brookes, AJ
Citation: Ja. Prince et al., Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease, EUR J HUM G, 9(6), 2001, pp. 437-444
Authors:
Gottfries, J
Blennow, K
Lehmann, MW
Regland, B
Gottfries, CG
Citation: J. Gottfries et al., One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis, J GER PSY N, 14(3), 2001, pp. 109-114
Authors:
Eriksson, M
Berggren, U
Blennow, K
Fahlke, C
Balldin, J
Citation: M. Eriksson et al., Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype, ALCOHOL, 24(1), 2001, pp. 15-23
Authors:
Sjogren, M
Blomberg, M
Jonsson, M
Wahlund, LO
Edman, A
Lind, K
Rosengren, L
Blennow, K
Wallin, A
Citation: M. Sjogren et al., Neurofilament protein in cerebrospinal fluid: A marker of white matter changes, J NEUROSC R, 66(3), 2001, pp. 510-516
Authors:
Sjogren, M
Gisslen, M
Vanmechelen, E
Blennow, K
Citation: M. Sjogren et al., Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment, NEUROSCI L, 314(1-2), 2001, pp. 33-36
Authors:
Erhardt, S
Blennow, K
Nordin, C
Skogh, E
Lindstrom, LH
Engberg, G
Citation: S. Erhardt et al., Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia, NEUROSCI L, 313(1-2), 2001, pp. 96-98
Authors:
Davidsson, P
Blennow, K
Andreasen, N
Eriksson, B
Minthon, L
Hesse, C
Citation: P. Davidsson et al., Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease, NEUROSCI L, 300(3), 2001, pp. 157-160
Authors:
Hesse, C
Rosengren, L
Andreasen, N
Davidsson, P
Vanderstichele, H
Vanmechelen, E
Blennow, K
Citation: C. Hesse et al., Transient increase in total tau but not phospho-tau in human cerebrospinalfluid after acute stroke, NEUROSCI L, 297(3), 2001, pp. 187-190
Authors:
Soderstrom, H
Blennow, K
Manhem, A
Forsman, A
Citation: H. Soderstrom et al., CSF studies in violent offenders - I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy, J NEURAL TR, 108(7), 2001, pp. 869-878
Authors:
Soderstrom, H
Blennow, K
Manhem, A
Forsman, A
Citation: H. Soderstrom et al., CSF studies in violent offenders - II. Blood-brain barrier dysfunction without concurrent inflammation or structure degeneration, J NEURAL TR, 108(7), 2001, pp. 879-886
Authors:
Sjogren, M
Hesse, C
Basun, H
Kol, G
Thostrup, H
Kilander, L
Marcusson, J
Edman, A
Wallin, A
Karlsson, I
Troell, M
Wachtmaister, G
Ekdahl, A
Olofsson, H
Sandstrom, A
Andreasen, N
Minthon, L
Blennow, K
Citation: M. Sjogren et al., Tacrine and rate of progression in Alzheimer's disease - relation to ApoE allele genotype, J NEURAL TR, 108(4), 2001, pp. 451-458
Authors:
Robertsson, B
Blennow, K
Brane, G
Edman, A
Karlsson, I
Wallin, A
Gottfries, CG
Citation: B. Robertsson et al., Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium, INT CLIN PS, 16(1), 2001, pp. 39-47
Authors:
Hesse, C
Nilsson, CL
Blennow, K
Davidsson, P
Citation: C. Hesse et al., Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry, ELECTROPHOR, 22(9), 2001, pp. 1834-1837
Authors:
Vanmechelen, E
Vanderstichele, H
Hulstaert, F
Andreasen, N
Minthon, L
Winblad, B
Davidsson, P
Blennow, K
Citation: E. Vanmechelen et al., Cerebrospinal fluid tau and beta-amyloid((I-42)) in dementia disorders, MECH AGE D, 122(16), 2001, pp. 2005-2011
Authors:
Chamoun, V
Zeman, A
Blennow, K
Fredman, P
Wallin, A
Keir, G
Giovannoni, G
Thompson, EJ
Citation: V. Chamoun et al., Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF, J NEUR SCI, 182(2), 2001, pp. 117-121
Authors:
Andreasen, N
Gottfries, J
Vanmechelen, E
Vanderstichele, H
Davidsson, P
Blennow, K
Rosengren, L
Blennow, K
Citation: N. Andreasen et al., Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease, J NE NE PSY, 71(4), 2001, pp. 557-558
Authors:
Sjogren, M
Davidsson, P
Tullberg, M
Minthon, L
Wallin, A
Wikkelso, C
Granerus, AK
Vanderstichele, H
Vanmechelen, E
Blennow, K
Citation: M. Sjogren et al., Both total and phosphorylated tau are increased in Alzheimer's disease, J NE NE PSY, 70(5), 2001, pp. 624-630
Authors:
Fabre, SF
Forsell, C
Viitanen, M
Sjogren, M
Wallin, A
Blennow, K
Blomberg, M
Andersen, C
Wahlund, LO
Lannfelt, L
Citation: Sf. Fabre et al., Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon 4 frequency, but no tau genemutations, EXP NEUROL, 168(2), 2001, pp. 413-418
Authors:
Sjogren, M
Vanderstichele, H
Agren, H
Zachrisson, O
Edsbagge, M
Wikkelso, C
Skoog, I
Wallin, A
Wahlund, LO
Marcusson, J
Nagga, K
Andreasen, N
Davidsson, P
Vanmechelen, E
Blennow, K
Citation: M. Sjogren et al., Tau and A beta 42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values, CLIN CHEM, 47(10), 2001, pp. 1776-1781